To statistically validate NSD2 mutations in primary paediatric ALL and see their prevalence in the different types of paediatric cancer, NSD2 coding exons were sequenced in approximately one thousand paediatric cancer samples. This evidence concerns the gene NSD2 and acute lymphoblastic leukemia.